Many pathways, including lipid and atherosclerosis (Fig. 5B), endocrine resistance pathway (Fig. 5C), prolactin signaling pathway (Fig. 5D), IL-17 signaling pathway (Fig. 5E), and others were involved in the mechanism of RPA in treating RLS. This evidence concerns the gene IL17A and atherosclerosis.